Exploring Some Challenges of the Pharmaceutical Cognitive Enhancement Discourse: Users and Policy Recommendations
- 24 August 2013
- journal article
- research article
- Published by Springer Nature in Neuroethics
- Vol. 7 (2) , 137-158
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Empirical Research on Attitudes Toward Cognitive Enhancement Is Essential to Inform Policy and Practice GuidelinesAJOB Primary Research, 2012
- Added Stakeholders, Added Value(s) to the Cognitive Enhancement Debate: Are Academic Discourse and Professional Policies Sidestepping Values of Stakeholders?AJOB Primary Research, 2012
- Smart Drugs “As Common As Coffee”: Media Hype about NeuroenhancementPLOS ONE, 2011
- Second thoughts on the prevalence of enhancementBioSocieties, 2010
- A call for data to inform discussion on cognitive enhancementBioSocieties, 2010
- Distinguishing Between Restoration and Enhancement in NeuropharmacologyAMA Journal of Ethics, 2010
- Enhancing genetic virtue?Politics and the Life Sciences, 2010
- Responding to requests from adult patients for neuroenhancementsNeurology, 2009
- Poll results: look who's dopingNature, 2008
- Neuroethics of Cognitive EnhancementBioSocieties, 2006